Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.29% | 18.47% | -66.70% | -67.23% | -69.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.29% | 18.47% | -66.70% | -67.23% | -69.88% |
| Cost of Revenue | 16.54% | -19.85% | -81.24% | -73.44% | -66.30% |
| Gross Profit | 82.00% | 29.69% | -62.20% | -65.46% | -70.78% |
| SG&A Expenses | 55.03% | 23.42% | -53.41% | -56.67% | -65.24% |
| Depreciation & Amortization | 145.77% | -13.49% | -86.64% | -96.04% | -91.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.22% | 14.75% | -59.86% | -61.49% | -66.70% |
| Operating Income | -11.62% | -2.97% | 34.73% | 40.65% | 56.27% |
| Income Before Tax | -26.50% | -10.01% | 68.57% | 58.87% | 69.49% |
| Income Tax Expenses | 1,035.86% | -- | 71.40% | 71.40% | 74.83% |
| Earnings from Continuing Operations | -130.12% | -76.19% | 78.86% | 70.95% | 81.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 204.36% | 206.44% | 10.99% | -9.37% | 0.34% |
| EBIT | -11.62% | -2.97% | 34.73% | 40.65% | 56.27% |
| EBITDA | -48.63% | -11.71% | 45.53% | 49.41% | 70.05% |
| EPS Basic | 202.67% | 204.33% | 12.65% | -7.64% | 1.41% |
| Normalized Basic EPS | -25.00% | -6.78% | 37.42% | 36.67% | 62.37% |
| EPS Diluted | 198.43% | 199.33% | 15.02% | -3.85% | 4.49% |
| Normalized Diluted EPS | -14.55% | 2.50% | 36.15% | 34.70% | 61.67% |
| Average Basic Shares Outstanding | 1.62% | 2.45% | 2.05% | 2.10% | 1.67% |
| Average Diluted Shares Outstanding | 2.16% | 2.98% | 2.50% | 2.28% | 3.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |